skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines TeplizumabQuestion & answer

Teplizumab · Medicine question

What immune-cell target does teplizumab bind to?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Teplizumab binds to CD3, a cell-surface antigen on T lymphocytes, including both CD4+ and CD8+ T cells.

Sources for this answer

Tzield 2 mg/2 mL concentrate for solution for infusionSANOFI · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated 15 August 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Teplizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about Teplizumab

Can Tzield (teplizumab) cause liver enzyme and bilirubin elevations without cytokine release syndrome?How is Tzield (teplizumab) administered?How much sodium and polysorbate 80 does each vial of Tzield (teplizumab) contain?What breastfeeding precautions are described for Tzield (teplizumab)?What precautions apply to Tzield (teplizumab) during pregnancy and before a planned pregnancy?What were the most frequently reported adverse reactions to Tzield (teplizumab) in clinical studies?

Read the Teplizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX